Higher comorbidities and early death in hospitalized African-American patients with Covid-19

Autor: Raavi Gupta, Raag Agrawal, Zaheer Bukhari, Absia Jabbar, Donghai Wang, John Diks, Mohamed Alshal, Dokpe Yvonne Emechebe, F. Charles Brunicardi, Jason M. Lazar, Robert Chamberlain, Aaliya Burza, M. A. Haseeb

Publikováno v: BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)

Abstract Background African-Americans/Blacks have suffered higher morbidity and mortality from COVID-19 than all other racial groups. This study aims to identify the causes of this health disparity, determine prognostic indicators, and assess efficac

Externí odkaz: https://doaj.org/article/f1cf21ae95c746c28ca0519126493b99

Early Experience With Methylprednisolone on SARS-CoV-2 Infection in the African American Population, a Retrospective Analysis

Autor: Subodh J Saggi, Sridesh Nath, Roshni Culas, Seema Chittalae, Aaliya Burza, Maya Srinivasan, Rishard Abdul, Benjamin Silver, Alnardo Lora, Ishmam Ibtida, Tanuj Chokshi, Violeta Capric, Ammar Mohamed, Samrat Worah, Jie OuYang, Patrick Geraghty, Angelika Gruessner, Moro O Salifu

Publikováno v: Clinical Medicine Insights: Circulatory, Respiratory and Pulmonary Medicine, Vol 14 (2020)

Background: Coronavirus disease-19 (COVID-19) is associated with acute kidney injury (AKI) and acute respiratory distress syndrome (ARDS) with high mortality rates. In African American (AA) populations, COVID-19 presentations and outcomes are more se

Externí odkaz: https://doaj.org/article/b5eec2e090cd422fb9806f452edcb917

Efficacy and safety of baricitinib for the treatment of hospitalised adults with COVID-19 (COV-BARRIER): a randomised, double-blind, parallel-group, placebo-controlled phase 3 trial

Autor: Vincent C Marconi, Athimalaipet V Ramanan, Stephanie de Bono, Cynthia E Kartman, Venkatesh Krishnan, Ran Liao, Maria Lucia B Piruzeli, Jason D Goldman, Jorge Alatorre-Alexander, Rita de Cassia Pellegrini, Vicente Estrada, Mousumi Som, Anabela Cardoso, Sujatro Chakladar, Brenda Crowe, Paulo Reis, Xin Zhang, David H Adams, E Wesley Ely, Mi-Young Ahn, Miriam Akasbi, Javier David Altclas, Federico Ariel, Horacio Alberto Ariza, Chandrasekhar Atkar, Anselmo Bertetti, Meenakshi Bhattacharya, Maria Luisa Briones, Akshay Budhraja, Aaliya Burza, Adrian Camacho Ortiz, Roberto Caricchio, Marcelo Casas, Valeria Cevoli Recio, Won Suk Choi, Emilia Cohen, Angel Comulada-Rivera, Paul Cook, Dora Patricia Cornejo Juarez, Carnevali Daniel, Luiz Fernando Degrecci Relvas, Jose Guillermo Dominguez Cherit, Todd Ellerin, Dmitry Enikeev, Suzana Erico Tanni Minamoto, Elie Fiss, Motohiko Furuichi, Kleber Giovanni Luz, Jason D. Goldman, Omar Gonzalez, Ivan Gordeev, Thomas Gruenewald, Victor Augusto Hamamoto Sato, Eun Young Heo, Jung Yeon Heo, Maria Hermida, Yuji Hirai, David Hutchinson, Claudio Iastrebner, Octavian Ioachimescu, Manish Jain, Maria Patelli Juliani Souza Lima, Akram Khan, Andreas E. Kremer, Thomas Lawrie, Mark MacElwee, Farah Madhani-Lovely, Vinay Malhotra, Michel Fernando Martínez Resendez, James McKinnell, Patrick Milligan, Cesar Minelli, Miguel Angel Moran Rodriguez, Maria Leonor Parody, Priscila Paulin, Priscilla Pemu, Ana Carolina Procopio Carvalho, Massimo Puoti, Joshua Purow, Mayur Ramesh, Alvaro Rea Neto, Philip Robinson, Cristhieni Rodrigues, Gustavo Rojas Velasco, Jose Francisco Kerr Saraiva, Morton Scheinberg, Stefan Schreiber, Dario Scublinsky, Anete Sevciovic Grumach, Imad Shawa, Jesus Simon Campos, Nidhi Sofat, Christoph D. Spinner, Eduardo Sprinz, Roger Stienecker, Jose Suarez, Natsuo Tachikawa, Hasan Tahir, Brian Tiffany, Alexander Vishnevsky, Adilson Westheimer Cavalcante, Kapil Zirpe

Publikováno v: The Lancet. Respiratory Medicine

Summary Background Baricitinib is an oral selective Janus kinase 1/2 inhibitor with known anti-inflammatory properties. This study evaluates the efficacy and safety of baricitinib in combination with standard of care for the treatment of hospitalised

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf64edd09bbf67d7978734149d4c838a
http://europepmc.org/articles/PMC8409066

OR and ICU teams ‘running in parallel’ at the end of cardiothoracic surgery improves perceptions of handoff safety

Autor: Frederic Joyce, Ahmad Saleh, Alexander Le, Safraz Hamid, Billy Yang, Robert Poston, Aaliya Burza

Publikováno v: BMJ Open Quality, Vol 10, Iss 1 (2021)
BMJ Open Quality

The transfer of a cardiac surgery patient from the operating room (OR) to the intensive care unit (ICU) is both a challenging process and a critical period for outcomes. Information transferred between these two teams—known as the ‘handoff’—h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa3c81a89c8498eec1e49161bf445886
https://bmjopenquality.bmj.com/content/10/1/e001001.full

Higher comorbidities and early death in hospitalized African-American patients with Covid-19

Autor: Absia Jabbar, F. Charles Brunicardi, Donghai Wang, Raag Agrawal, Aaliya Burza, D Emechebe, Zaheer Bukhari, Jason Lazar, M A Haseeb, Mohamed Alshal, Raavi Gupta, Robert Chamberlain, John Diks

Publikováno v: BMC Infectious Diseases, Vol 21, Iss 1, Pp 1-11 (2021)
BMC Infectious Diseases

Background African-Americans/Blacks have suffered higher morbidity and mortality from COVID-19 than all other racial groups. This study aims to identify the causes of this health disparity, determine prognostic indicators, and assess efficacy of trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b39b3c038b2ae807cd9df6a42bbe8744
https://doi.org/10.1186/s12879-021-05782-9